MK 1308

Alternative Names:
MK-1308

Latest Information Update: 24 Jul 2017

Price :
*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator
Merck AG

Class
Antineoplastics; Biological factors

Mechanism of Action
Cytotoxic T-lymphocyte antigen 4 inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.